Company Filing History:
2 out of 2,078 
1 out of 188 
1 out of 257 
Years Active: 1995-2015
Title: The Innovative Journey of Inventor Lorraine Scott
Introduction
Lorraine Scott is a prominent inventor based in North Wales, PA, known for her groundbreaking work in the pharmaceutical field. With a total of four patents to her name, she has made significant contributions to the development of compounds that inhibit specific sodium-dependent glucose transporters (SGLT).
Latest Patents
One of Lorraine's latest patents is focused on a novel process for the preparation of compounds that serve as inhibitors of SGLT. This invention is pivotal in addressing conditions related to glucose absorption in the intestine or kidney. Additionally, she holds patents for compounds exhibiting inhibitory activity against sodium-dependent glucose transporters, which include various pharmaceutically acceptable salts and prodrugs, along with effective pharmaceutical compositions and treatment methods.
Career Highlights
Throughout her career, Lorraine has worked for reputable companies such as Janssen Pharmaceutica and McNeil, where her innovations have garnered acclaim and added value to the pharmaceutical industry. Her experience in these organizations has equipped her with a robust skill set in research and development.
Collaborations
Lorraine has collaborated with esteemed professionals in her field, including Frank John Villani, Jr., and Cynthia Anne Maryanoff. These partnerships have enhanced her research and have led to the successful completion of her innovative projects.
Conclusion
In conclusion, Lorraine Scott stands out as a trailblazer in the field of pharmaceuticals, with her inventive spirit and significant contributions through her patents. Her work continues to impact the medical community, making strides in the treatment and management of glucose-related health issues.